Phenylephrine HCl 0.9% Sodium Chloride Injection USP
cGMP violations
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,535 recalls, newest first.
cGMP violations
CGMP violations
Crystallization
Defective Delivery System: The dip tube is clogged causing the spray not to work.
Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.
CGMP deviations
CGMP deviations
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Temperature abuse: Products exposed to improper temperature above drug label specifications.
cGMP Deviations: Temperature excursion
Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000.
Lack of Assurance of Sterility
Failed Dissolution Specifications
Microbial Contamination of Non-Sterile Product
Subpotent Drug
Microbial contamination of non-sterile Products -
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.